NO20004198L - FremgangsmÕte for behandling av diabetes ved anvendelse av peptidanaloger av insulin - Google Patents
FremgangsmÕte for behandling av diabetes ved anvendelse av peptidanaloger av insulinInfo
- Publication number
- NO20004198L NO20004198L NO20004198A NO20004198A NO20004198L NO 20004198 L NO20004198 L NO 20004198L NO 20004198 A NO20004198 A NO 20004198A NO 20004198 A NO20004198 A NO 20004198A NO 20004198 L NO20004198 L NO 20004198L
- Authority
- NO
- Norway
- Prior art keywords
- insulin
- treating diabetes
- peptide analogues
- analogues
- peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2815698A | 1998-02-23 | 1998-02-23 | |
| PCT/US1999/003915 WO1999042482A1 (en) | 1998-02-23 | 1999-02-23 | Methods for treatment of diabetes using peptide analogues of insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004198D0 NO20004198D0 (no) | 2000-08-22 |
| NO20004198L true NO20004198L (no) | 2000-10-20 |
Family
ID=21841884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004198A NO20004198L (no) | 1998-02-23 | 2000-08-22 | FremgangsmÕte for behandling av diabetes ved anvendelse av peptidanaloger av insulin |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6197926B1 (ru) |
| EP (1) | EP1056776A1 (ru) |
| JP (1) | JP2002504491A (ru) |
| KR (1) | KR20010041238A (ru) |
| CN (1) | CN1241942C (ru) |
| AP (1) | AP2000001888A0 (ru) |
| AU (1) | AU741037B2 (ru) |
| BR (1) | BR9908178A (ru) |
| CA (1) | CA2321929A1 (ru) |
| EA (1) | EA003944B1 (ru) |
| HU (1) | HUP0100928A3 (ru) |
| ID (1) | ID26788A (ru) |
| IL (1) | IL137904A0 (ru) |
| NO (1) | NO20004198L (ru) |
| NZ (1) | NZ506447A (ru) |
| OA (1) | OA11453A (ru) |
| PL (1) | PL342517A1 (ru) |
| SK (1) | SK12412000A3 (ru) |
| TR (1) | TR200003048T2 (ru) |
| WO (1) | WO1999042482A1 (ru) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562942B1 (en) * | 1999-02-23 | 2003-05-13 | Neurocrine Biosciences, Inc. | Methods for treatment of diabetes using peptide analogues of insulin |
| CN1125081C (zh) * | 1999-09-08 | 2003-10-22 | 中国科学院上海生物化学研究所 | 重组天然和新型人胰岛素及其制备方法 |
| US7462486B2 (en) * | 2000-05-12 | 2008-12-09 | Oregon Health & Science University | Methods of selecting T cell receptor V peptides for therapeutic use |
| AU5984701A (en) * | 2000-05-12 | 2001-11-20 | Univ Oregon Health & Science | Method of treating immune pathologies with low dose estrogen |
| US20020103131A1 (en) * | 2001-01-26 | 2002-08-01 | Jacobson Jill D. | Prevention of diabetes by administration of GnRH antagonists |
| US20070172453A1 (en) * | 2002-08-30 | 2007-07-26 | Vincent Geenen | Tolerogenic approach for type 1 diabetes |
| US20040138116A1 (en) * | 2002-08-30 | 2004-07-15 | Vincent Geenen | Tolerogenic approach for type 1 diabetes |
| CA2501318A1 (en) | 2002-10-10 | 2004-04-22 | Yeda Research And Development Co. Ltd | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| JP2006526651A (ja) * | 2003-06-02 | 2006-11-24 | マーシア・ファーマ・インコーポレイテッド | １型糖尿病の処置のための治療的ワクチン組成物 |
| US8053197B2 (en) * | 2004-07-30 | 2011-11-08 | Oregon Health & Science University | Methods for detecting and treating autoimmune disorders |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| CA2711749A1 (en) | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Novel insulin derivatives having an extremely delayed time-action profile |
| DE102008003566A1 (de) * | 2008-01-09 | 2009-07-16 | Sanofi-Aventis Deutschland Gmbh | Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil |
| WO2009099763A1 (en) | 2008-01-30 | 2009-08-13 | Indiana University Research And Technology Corporation | Ester-based peptide prodrugs |
| RS56632B1 (sr) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| AU2009335715B2 (en) | 2008-12-19 | 2016-09-15 | Indiana University Research And Technology Corporation | Amide-based insulin prodrugs |
| WO2010080606A1 (en) * | 2008-12-19 | 2010-07-15 | Indiana University Research And Technology Corporation | Insulin analogs |
| AU2010317995B2 (en) | 2009-11-13 | 2014-04-17 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine |
| CN102711804B (zh) | 2009-11-13 | 2015-09-16 | 赛诺菲-安万特德国有限公司 | 包含glp-1激动剂和甲硫氨酸的药物组合物 |
| US20110311536A1 (en) * | 2010-06-11 | 2011-12-22 | Dana-Farber Cancer Institute, Inc. | Prevention of type 1 diabetes by treg vaccination with an insulin mimetope |
| CA2802485C (en) | 2010-06-16 | 2019-09-17 | Indiana University Research And Technology Corporation | Single chain insulin agonists exhibiting high activity at the insulin receptor |
| CN103119057B (zh) | 2010-06-24 | 2016-06-15 | 印第安纳大学研究及科技有限公司 | 基于酰胺的胰岛素前药 |
| JP6199186B2 (ja) | 2010-08-30 | 2017-09-20 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| UA113626C2 (xx) * | 2011-06-02 | 2017-02-27 | Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії | |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| JP6392123B2 (ja) | 2011-12-20 | 2018-09-19 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ | 糖尿病治療のためのｃｔｐ系インスリンアナローグ |
| EP3395358B1 (en) | 2012-09-26 | 2019-11-06 | Indiana University Research and Technology Corporation | Insulin analog dimers |
| US20160024169A1 (en) | 2013-03-14 | 2016-01-28 | Indiana University Research And Technology Corporation | Insulin-incretin conjugates |
| WO2016049190A1 (en) | 2014-09-24 | 2016-03-31 | Indiana University Research And Technology Corporation | Incretin-insulin conjugates |
| JP6701208B2 (ja) | 2014-09-24 | 2020-05-27 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | 脂質化アミド系インスリンプロドラッグ |
| MX2017007699A (es) | 2014-12-12 | 2017-09-18 | Sanofi Aventis Deutschland | Formulacion de proporcion fija de insulina glargina/lixisenatida. |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| CN111925420B (zh) * | 2019-12-11 | 2022-04-01 | 山东大学 | 一种多肽作为嗅觉受体Olfr109激动剂配体的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5008241A (en) * | 1985-03-12 | 1991-04-16 | Novo Nordisk A/S | Novel insulin peptides |
| PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| US5559094A (en) * | 1994-08-02 | 1996-09-24 | Eli Lilly And Company | AspB1 insulin analogs |
| US5594100A (en) * | 1995-02-22 | 1997-01-14 | Regents Of The University Of Colorado | Epitope for prevention of type I diabetes |
| JPH11509195A (ja) * | 1995-06-30 | 1999-08-17 | ノボ ノルディスク アクティーゼルスカブ | 糖尿病の特徴を有する疾患の予防 |
-
1999
- 1999-02-23 CN CNB998042765A patent/CN1241942C/zh not_active Expired - Fee Related
- 1999-02-23 EP EP99908385A patent/EP1056776A1/en not_active Withdrawn
- 1999-02-23 KR KR1020007009330A patent/KR20010041238A/ko active IP Right Grant
- 1999-02-23 HU HU0100928A patent/HUP0100928A3/hu unknown
- 1999-02-23 ID IDW20001917A patent/ID26788A/id unknown
- 1999-02-23 BR BR9908178-4A patent/BR9908178A/pt not_active IP Right Cessation
- 1999-02-23 AU AU27831/99A patent/AU741037B2/en not_active Ceased
- 1999-02-23 IL IL13790499A patent/IL137904A0/xx unknown
- 1999-02-23 PL PL99342517A patent/PL342517A1/xx not_active Application Discontinuation
- 1999-02-23 TR TR2000/03048T patent/TR200003048T2/xx unknown
- 1999-02-23 WO PCT/US1999/003915 patent/WO1999042482A1/en not_active Application Discontinuation
- 1999-02-23 NZ NZ506447A patent/NZ506447A/xx unknown
- 1999-02-23 EA EA200000872A patent/EA003944B1/ru not_active IP Right Cessation
- 1999-02-23 SK SK1241-2000A patent/SK12412000A3/sk unknown
- 1999-02-23 US US09/255,668 patent/US6197926B1/en not_active Expired - Fee Related
- 1999-02-23 JP JP2000532434A patent/JP2002504491A/ja active Pending
- 1999-02-23 CA CA002321929A patent/CA2321929A1/en not_active Abandoned
- 1999-02-23 AP APAP/P/2000/001888A patent/AP2000001888A0/en unknown
-
2000
- 2000-08-22 NO NO20004198A patent/NO20004198L/no unknown
- 2000-08-22 OA OA1200000229A patent/OA11453A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA11453A (en) | 2003-12-08 |
| TR200003048T2 (tr) | 2000-12-21 |
| KR20010041238A (ko) | 2001-05-15 |
| AU2783199A (en) | 1999-09-06 |
| HUP0100928A3 (en) | 2001-11-28 |
| WO1999042482A1 (en) | 1999-08-26 |
| CA2321929A1 (en) | 1999-08-26 |
| NZ506447A (en) | 2002-11-26 |
| US6197926B1 (en) | 2001-03-06 |
| EA200000872A1 (ru) | 2001-02-26 |
| IL137904A0 (en) | 2001-10-31 |
| PL342517A1 (en) | 2001-06-18 |
| NO20004198D0 (no) | 2000-08-22 |
| BR9908178A (pt) | 2002-01-15 |
| ID26788A (id) | 2001-02-08 |
| AU741037B2 (en) | 2001-11-22 |
| EP1056776A1 (en) | 2000-12-06 |
| EA003944B1 (ru) | 2003-10-30 |
| JP2002504491A (ja) | 2002-02-12 |
| CN1241942C (zh) | 2006-02-15 |
| CN1294597A (zh) | 2001-05-09 |
| HUP0100928A2 (hu) | 2001-08-28 |
| AP2000001888A0 (en) | 2000-09-30 |
| SK12412000A3 (sk) | 2002-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004198L (no) | FremgangsmÕte for behandling av diabetes ved anvendelse av peptidanaloger av insulin | |
| NO20001195D0 (no) | Bruddheling ved anvendelse av PTHrP-analoger | |
| PL342745A1 (en) | Method of administering monomeric insulin analoques | |
| DE69826705D1 (de) | Verfahren zur dermalen verabreichung von polypeptiden | |
| DE59909597D1 (de) | Verfahren zur kontrolle der insulinmedikation | |
| DE69817446D1 (de) | Behandlung von diabetes | |
| ID23172A (id) | Metode yang diperbaiki untuk pengolahan protein c teraktivasi | |
| NO20010982D0 (no) | FremgangsmÕte for Õ administrere insulinotropiske peptider | |
| PL328108A1 (en) | Method of obtaining precursors of insulin | |
| PL334495A1 (en) | Method of treating lupiform nephritis using substances acting against cd40l | |
| DE69718835D1 (de) | Verfahren zur Herstellung von (N-Phenylacetyl-N-2,6-xylyl)methyl Alaninat | |
| NO995996D0 (no) | Fremgangsmåte for behandling av fedme | |
| DE59804785D1 (de) | Verbessertes Verfahren zur Stabilisierung von Proteinen | |
| IL115603A0 (en) | Method of treating diabetes mellitus using kgf | |
| HK1042852A1 (zh) | 增強胰島素反應的方法 | |
| DK0970266T3 (da) | Fremgangsmåde til overfladebehandling ved nedsænkning | |
| DE59801891D1 (de) | Verfahren zum thermischen behandeln von flüchtige, brennbare bestandteile enthaltendem material | |
| EP0999848A4 (en) | CHIMEAN PROTEINS FOR TREATING DIABETES | |
| DE69832649D1 (de) | Verfahren zur Abgasbehandlung | |
| NO963366D0 (no) | Peptider og fremgangsmåte for behandling av diabetes | |
| DE990441T1 (de) | Arzneimittel zur behandlung von diabetischer nephrosis | |
| NO20006383D0 (no) | Fremgangsmåte for behandling | |
| DE59907234D1 (de) | Verfahren zur aufarbeitung von diarylcarbonathaltigen reaktionsmischungen | |
| UA34041A (uk) | Спосіб лікування цукрового діабету | |
| EP1215499A4 (en) | METHOD FOR SEARCHING FOR A SUBSTANCE FOR CONTROLLING INFLUENZA VIRUS |